Perhexiline	perhexiline	CHEMICALS	O	OTHERS	I
maleate	maleate	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
peripheral	peripheral	O	DISEASE	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Peripheral	peripheral	O	DISEASE	OTHERS	I
neuropathy	neuropathy	O	DISEASE	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
noted	noted	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
complication	complication	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
with	with	O	O	O	O
perhexiline	perhexiline	CHEMICALS	O	OTHERS	I
maleate	maleate	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
drug	drug	O	O	O	O
widely	widely	O	O	O	O
used	used	O	O	O	O
in	in	O	O	O	O
France	france	O	O	O	O
(	(	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
trials	trials	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
United	united	O	O	O	O
States	states	O	O	O	O
)	)	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
prophylactic	prophylactic	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
angina	angina	O	DISEASE	OTHERS	I
pectoris	pectoris	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
24	24	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
this	this	O	O	O	O
complication	complication	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
marked	marked	O	O	O	O
slowing	slowing	O	O	O	O
of	of	O	O	O	O
motor	motor	O	O	O	O
nerve	nerve	O	O	O	O
conduction	conduction	O	O	O	O
velocity	velocity	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
electromyographic	electromyographic	O	O	O	O
changes	changes	O	O	O	O
imply	imply	O	O	O	O
mainly	mainly	O	O	O	O
a	a	O	O	O	O
demyelinating	demyelinating	O	O	OTHERS	I
disorder	disorder	O	O	OTHERS	I
.	.	O	O	O	O

Improvement	improvement	O	O	O	O
was	was	O	O	O	O
noted	noted	O	O	O	O
with	with	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
a	a	O	O	O	O
few	few	O	O	O	O
cases	cases	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
active	active	O	O	O	O
denervation	denervation	O	O	O	O
signified	signified	O	O	O	O
a	a	O	O	O	O
poor	poor	O	O	O	O
prognosis	prognosis	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
only	only	O	O	O	O
slight	slight	O	O	O	O
improvement	improvement	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
underlying	underlying	O	O	O	O
mechanism	mechanism	O	O	O	O
causing	causing	O	O	O	O
the	the	O	O	O	O
neuropathy	neuropathy	O	DISEASE	OTHERS	I
is	is	O	O	O	O
not	not	O	O	O	O
yet	yet	O	O	O	O
fully	fully	O	O	O	O
known	known	O	O	O	O
,	,	O	O	O	O
although	although	O	O	O	O
some	some	O	O	O	O
evidence	evidence	O	O	O	O
indicates	indicates	O	O	O	O
that	that	O	O	O	O
it	it	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
lipid	lipid	O	O	O	O
storage	storage	O	O	O	O
process	process	O	O	O	O
.	.	O	O	O	O

